Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1295 studies found for:    Ovarian Cancer: Clinical Trials
Show Display Options
Download search resultsDownload the search results for:
Ovarian Cancer: Clinical Trials (1295 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Enrolling by invitation An Exercise Intervention Trial to Reduce Symptoms & Improve Clinical Outcomes of Platinum-Based Treatment in Ovarian Cancer Patients
Condition: Ovarian Carcinoma
Interventions: Behavioral: Exercise Intervention;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration
2 Active, not recruiting
Has Results
Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial)
Conditions: Ovarian Carcinoma;   Ovarian Germ Cell Tumor
Interventions: Other: Laboratory Biomarker Analysis;   Other: Screening Questionnaire Administration;   Procedure: Ultrasonography
3 Recruiting A Phase 1 Trial of Perfusion Induced Systemic Hyperthermia (PISH) Over Multiple Cycles for Terminal Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Device: ThermalCore Hyperthermia System
4 Recruiting To Evaluate Plasmajet in Achieving Complete Cytoreduction of Advanced EOC- Initial Feasibility Study
Condition: Epithelial Ovarian Cancer
Intervention: Device: Surgery for EOC with trial (PJ) device (PlasmaJet)
5 Recruiting Clinical Trial of Lurbinectedin (PM01183) in Platinum Resistant Ovarian Cancer Patients
Condition: Ovarian Cancer
Interventions: Drug: Lurbinectedin (PM01183);   Drug: Pegylated liposomal doxorubicin (PLD);   Drug: Topotecan
6 Recruiting Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) in Ovarian Cancer Recurrence
Condition: First Recurrence of Ovarian Cancer
Interventions: Procedure: Secondary citoreduction;   Procedure: Hyperthermic intra-peritoneal chemotherapy (HIPEC)
7 Unknown  Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Other: Early detection
8 Completed Clinical Trial Investigating Pazopanib in Patients With Platinum-resistant Advanced Ovarian Cancer
Condition: Platinum-resistant Advanced Ovarian Cancer
Intervention: Drug: Pazopanib
9 Completed
Has Results
Trial of Decitabine as a Sensitizer to Carboplatin in Platinum Resistant Recurrent Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: decitabine
10 Completed
Has Results
Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma
Conditions: Ovarian Carcinoma;   Peritoneal Neoplasms
Intervention: Drug: Docetaxel and Gemcitabine
11 Recruiting Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial
Conditions: Epithelial Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Carcinoma
Interventions: Drug: Paclitaxel(intravenous) + Carboplatin(intravenous);   Drug: Paclitaxel(intravenous) + Carboplatin(intraperitoneal)
12 Active, not recruiting Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Conditions: Ovarian Cancer;   Peritoneal Cancer;   Fallopian Tube Cancer
Intervention: Procedure: Tumor collection
13 Completed
Has Results
Open Trial of Bendamustine Hydrochloride in Women With Advanced Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Bendamustine HCL
14 Unknown  Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective, Randomized Phase II Clinical Trial
Condition: Ovarian Neoplasms
Intervention: Procedure: neoadjuvant chemotherapy (Carboplatin/Docetaxel)
15 Active, not recruiting An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: cediranib
16 Active, not recruiting Trial of Adjuvant FANG™ Vaccine for High Risk Stage III/IV Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Biological: Vigil™
17 Recruiting EWOC-1 Trial: Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Stage III-IV Advanced Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Paclitaxel + Carboplatin every 3 weeks;   Drug: Carboplatin monotherapy every 3 weeks;   Drug: Weekly Paclitaxel and Carboplatin
18 Withdrawn Economic Outcomes in Patients With Stage III Ovarian Cancer Receiving Paclitaxel and Cisplatin on Clinical Trial GOG-172
Condition: Ovarian Cancer
Intervention: Procedure: quality-of-life assessment
19 Unknown  Clinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA)
Conditions: Cancer.;   Melanoma.;   Ovarian Cancer.;   Lung Cancer.
Interventions: Biological: NY-ESO-1 combined with MPLA;   Biological: NY-ESO-1 combined with MPLA vaccine
20 Recruiting Trial on Radical Upfront Surgery in Advanced Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Procedure: PDS;   Drug: 6 cycles of standard chemotherapy;   Drug: 3 cycles of standard NACT;   Procedure: IDS;   Drug: 3 cycles of standard chemotherapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years